Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Hudson Technologies, Inc.    HDSN

HUDSON TECHNOLOGIES, INC.

(HDSN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

HUDSON TECHNOLOGIES INC /NY : Regulation FD Disclosure (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 04:15pm EDT
Item 7.01 Regulation FD



On August 9, 2019, Hudson Technologies, Inc. (the "Company") filed a Form 12b-25 (the "Form") with the Securities and Exchange Commission indicating that the Company will not be in a position to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019, but intends to do so within the 5-day extension period provided in Rule 12b-25(b) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").



The Form stated that:


Hudson Technologies, Inc. (the "Company") was not in compliance with (i) the total leverage ratio covenant, calculated as of June 30, 2019, set forth in its Term Loan Credit and Security Agreement, as amended, with U.S. Bank National Association, as agent, and the term loan lenders (the "Term Loan") and (ii) the minimum liquidity covenant under the Term Loan at July 31, 2019. The Company was also not in compliance with the minimum EBITDA covenant for the four quarters ended June 30, 2019 set forth in its Amended and Restated Revolving Credit and Security Agreement, as amended (the "Revolving Facility"), with PNC Bank, National Association, as administrative agent, collateral agent and lender, PNC Capital Markets LLC as lead arranger and sole bookrunner, and such other lenders thereunder.

The Company is currently seeking a waiver and/or amendment from its lenders under both the Term Loan and the Revolving Facility, which the Company is working to complete on or before August 14, 2019. As a result of the impact of foregoing discussions, the Company is not in a position to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 (the "10-Q") on a timely basis. The Company is working diligently to resolve these matters and management currently believes that the Company will be in a position to file the aforementioned 10-Q not later than August 14, 2019.

The Form also provided the following preliminary financial information for the quarter and six months ended June 30, 2019:

For the quarter ended June 30, 2019, the Company's revenues were $56.0 million, a decrease of 3% compared to $57.8 million in the comparable 2018 period. The Company recorded lower of cost or net realizable value adjustments to its inventory of $9.2 million and $34.7 million during the second quarter of 2019 and 2018, respectively. Due in part to the impact of the inventory adjustments referenced above, the Company's preliminary net loss for the second quarter of 2019 was $13.7 million, or ($0.32) per basic and diluted share, compared to a net loss of $30.6 million or ($0.72) per basic and diluted share in the second quarter of 2018.

For the six months ended June 30, 2019, the Company's revenues were $90.7 million, a decrease of 10% compared to $100.3 million in the comparable 2018 period. Due in part to the impact of the inventory adjustments referenced above, the Company's preliminary net loss for the first half of 2019 was $17.8 million, or ($0.42) per basic and diluted share, compared to a net loss of $33.7 million or ($0.79) per basic and diluted share in the first half of 2018.





  2





The Company issued a press release on August 14, 2019 announcing its financial results for the second quarter and six-month period ended June 30, 2019. The press release is attached hereto as Exhibit 99.1. The information in this Item and the aforementioned press release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into any filing of the Company, whether made before or after the date of this report, regardless of any general incorporation language in the filing.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HUDSON TECHNOLOGIES, INC.
08/14HUDSON TECHNOLOGIES : NY Management's Discussion and Analysis of Financial Condi..
AQ
08/14HUDSON TECH : 2Q Earnings Snapshot
AQ
08/14HUDSON TECHNOLOGIES INC /NY : Regulation FD Disclosure (form 8-K)
AQ
08/14Hudson Technologies Reports Second Quarter 2019 Results and Receives $8.9 Mil..
GL
08/07HUDSON TECHNOLOGIES : to Host Conference Call to Discuss Second Quarter 2019 Res..
PU
08/07Hudson Technologies to Host Conference Call to Discuss Second Quarter 2019 Re..
GL
08/02HUDSON TECHNOLOGIES INC /NY : Notice of Delisting or Failure to Satisfy a Contin..
AQ
06/11HUDSON TECHNOLOGIES INC /NY : Submission of Matters to a Vote of Security Holder..
AQ
05/02HUDSON TECHNOLOGIES : NY Management's Discussion and Analysis of Financial Condi..
AQ
05/01HUDSON TECH : 1Q Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2019 163 M
EBIT 2019 0,93 M
Net income 2019 -13,0 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -1,33x
P/E ratio 2020 -20,0x
Capi. / Sales2019 0,10x
Capi. / Sales2020 0,09x
Capitalization 17,0 M
Chart HUDSON TECHNOLOGIES, INC.
Duration : Period :
Hudson Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUDSON TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 0,80  $
Last Close Price 0,40  $
Spread / Highest target 150%
Spread / Average Target 100%
Spread / Lowest Target 50,0%
EPS Revisions
Managers
NameTitle
Kevin J. Zugibe Chairman & Chief Executive Officer
Brian F. Coleman President, Chief Operating Officer & Director
Nat Krishnamurti Chief Financial Officer & Vice President
Otto C. Morch Independent Director
Dominic J. Monetta Independent Director
Sector and Competitors